Drug-Resistant Stomach Bug Infections Surge Across America

A Growing Medical Challenge

A dangerous new reality is emerging in American hospitals and clinics: a common stomach bug that once responded to standard antibiotics is becoming virtually untreatable. The Centers for Disease Control and Prevention reports that "extensively drug-resistant" bacteria caused about 9% of shigellosis cases in 2023, up from 0% in 2011, with the proportion of XDR isolates rising to 8.5% in 2023 . This alarming trend represents one of the most significant antibiotic resistance developments in recent years.

Shigella, the bacteria behind this stomach illness, has developed resistance to all five commonly recommended antibiotics: ampicillin, azithromycin, ceftriaxone, ciprofloxacin, and trimethoprim-sulfamethoxazole . No Food and Drug Administration-approved oral antimicrobial agents are available to treat these extensively drug-resistant infections , leaving doctors scrambling for alternatives when patients don't recover on their own.

The CDC's analysis examined nearly 17,000 bacterial samples over a 12-year span , revealing a concerning pattern that has public health officials on high alert. The Centers for Disease Control & Prevention has called the rise of drug-resistant Shigella infections a "public health threat" .

Who's Most at Risk

The demographics of this outbreak reveal an important shift from traditional patterns. Historically, U.S. outbreaks primarily affected children and involved drug-susceptible strains, but the majority of XDR cases occurred among adult men, who represented 86.2 percent of patients, with a median age of 41 years . Most outbreaks of drug resistant strains have been reported among adults who are international travelers, men who have sex with men (MSM), those living with HIV or experiencing homelessness, with the highest proportion of XDR cases among adult men (85%) .

More than a third of the extensively drug-resistant cases resulted in hospitalization, with people with weakened immune systems more vulnerable to severe shigellosis, which can cause dehydration, kidney damage and infections of the bloodstream . About one in three infected patients required hospitalization, and among the people who provided their HIV status, nearly half were infected with the virus .

Travel history data suggested that most infections were domestically acquired, with 76.2 percent reporting no recent domestic travel, and 82.4 percent reporting no recent international travel , indicating the bacteria is spreading within American communities rather than being imported from abroad.

Symptoms and Treatment Challenges

Symptoms of shigellosis include fever, stomach pain and diarrhea that can be bloody and last for days . Most people infected with Shigella will experience diarrhea (which can be bloody and prolonged), fever and stomach pain, starting one or two days after exposure, with symptoms typically lasting for five to seven days, but some people may experience prolonged sickness for several weeks .

The treatment landscape has become particularly challenging for healthcare providers. "Treatment of XDR shigellosis remains challenging because no optimal therapy has been established," with clinicians "really relying on scant anecdotal data" in terms of managing their patients . The CDC report notes that oral carbapenems, pivmecillinam, and fosfomycin may be effective, but none have been approved by the Food and Drug Administration for shigellosis .

Most people with diarrheal illness require only supportive care and fluid replacement, with antimicrobial agents not always needed for mild shigellosis . However, when antibiotics are necessary for severe cases, doctors face limited options and must often resort to experimental treatments.

Looking Ahead: Prevention and Surveillance

The rapid emergence of this drug-resistant strain has researchers concerned about broader implications. "It's almost like an explosion of this pathogen in the community," according to researchers at UCLA Health who have seen cases increase from one in 2022 to roughly one case per month . There's concern that if XDR strains become a more frequent cause of foodborne illness and spread beyond at-risk populations, "having such resistant bacteria that is also highly contagious in the community is never a good thing" .

Antibiotic resistance is seen by public health experts as an urgent and rising threat, as when antibiotics are given, more resilient bacteria may survive and multiply, develop stronger defenses through mutation, with overuse of antibiotics accelerating this process and limiting the effectiveness of these drugs when they're truly needed .

The CDC continues to emphasize the importance of prevention through basic hygiene measures and has called for enhanced surveillance and reporting of cases. As this resistant strain continues to spread, the medical community faces the sobering reality that common infections may become increasingly difficult to